Skip to main content
SpringerLink
Log in

Newborn Screening by Tandem Mass Spectrometry and Molecular Confirmation

  • Chapter
  • First Online:
Book cover Molecular Diagnostics

Part of the book series: Molecular and Translational Medicine ((MOLEMED))

  • 2155 Accesses

Abstract

Over the last several of decades, newborn screening (NBS) has rapidly expanded from the application of a single test to identify a severe but treatable disorder in presymptomatic newborns in order to provide therapy and prevent disease, to a complex and important health program.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bickel H. The effects of a phenylalanine-free and phenylalanine-poor diet in phenylpyruvic oligophrenis. Exp Med Surg. 1954;12(1):114–7.

    CAS  PubMed  Google Scholar 

  2. Cunningham GC. Phenylketonuria testing—its role in pediatrics and public health. CRC Crit Rev Clin Lab Sci. 1971;2(1):45–101.

    Article  CAS  PubMed  Google Scholar 

  3. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338–43.

    CAS  PubMed  Google Scholar 

  4. Naylor EW, Guthrie R. Newborn screening for maple syrup urine disease (branched-chain ketoaciduria). Pediatrics. 1978;61(2):262–6.

    CAS  PubMed  Google Scholar 

  5. Murphey WH, Patchen L, Guthrie R. Screening tests for argininosuccinic aciduria, orotic aciduria, and other inherited enzyme deficiencies using dried blood specimens. Biochem Genet. 1972;6(1):51–9.

    Article  CAS  PubMed  Google Scholar 

  6. Dussault JH, Coulombe P, Laberge C, Letarte J, Guyda H, Khoury K. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr. 1975;86(5):670–4.

    Article  CAS  PubMed  Google Scholar 

  7. Pang S, Hotchkiss J, Drash AL, Levine LS, New MI. Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1977;45(5):1003–8.

    Article  CAS  PubMed  Google Scholar 

  8. Thielmann K, Moreira Aquino A. Whole blood samples dried and stored on filter paper as substrate for the electrophoretic separation on hemoglobin S from hemoglobin A. A screening procedure. Clin Chim Acta. 1971;35(1):237–8.

    Article  CAS  PubMed  Google Scholar 

  9. Millington DS, Norwood DL, Kodo N, Roe CR, Inoue F. Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood, and tissue. Anal Biochem. 1989;180(2):331–9.

    Article  CAS  PubMed  Google Scholar 

  10. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis. 1990;13(3):321–4.

    Article  CAS  PubMed  Google Scholar 

  11. Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Hofman LF. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem. 1993;39(1):66–71.

    CAS  PubMed  Google Scholar 

  12. Wilson JM, Junger G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968.

    Google Scholar 

  13. McHugh DM, Cameron CA, Abdenur JE, et al. Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med. 2011;13(3):230–54.

    Article  PubMed  Google Scholar 

  14. Matern D, Tortorelli S, Oglesbee D, Gavrilov D, Rinaldo P. Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004–2007). J Inherit Metab Dis. 2007;30(4):585–92.

    Article  CAS  PubMed  Google Scholar 

  15. Pass KA, Morrissey M. Enhancing newborn screening for tyrosinemia type I. Clin Chem. 2008;54(4):627–9.

    Article  CAS  PubMed  Google Scholar 

  16. Turgeon C, Magera MJ, Allard P, et al. Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots. Clin Chem. 2008;54(4):657–64.

    Article  CAS  PubMed  Google Scholar 

  17. Texas Supplied Newborn Blood Samples to Forensic Database. AAAS, 2010. http://news.sciencemag.org/scienceinsider/2010/02/texas-supplied-newborn-blood-sam.html (2010). Accessed 23 Nov 2011.

  18. Marquardt G, et al. Enhanced interpretation of newborn screening results without analyte cutoff values. Genet Med. 2012;14(7):648–55.

    Google Scholar 

  19. Boneh A, Andresen BS, Gregersen N, et al. VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis. Mol Genet Metab. 2006;88(2):166–70.

    Article  CAS  PubMed  Google Scholar 

  20. Desviat LR, Perez B, Belanger-Quintana A, et al. Tetrahydrobiopterin responsiveness: results of the BH4 loading test in 31 Spanish PKU patients and correlation with their genotype. Mol Genet Metab. 2004;83(1–2):157–62.

    Article  CAS  PubMed  Google Scholar 

  21. Timmermans S, Buchbinder M. Patients-in-waiting: living between sickness and health in the genomics era. J Health Soc Behav. 2010;51(4):408–23.

    Article  PubMed  Google Scholar 

  22. Venditti LN, Venditti CP, Berry GT, et al. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis. Pediatrics. 2003;112(5):1005–15.

    Article  PubMed  Google Scholar 

  23. Norman R, Haas M, Chaplin M, Joy P, Wilcken B. Economic evaluation of tandem mass spectrometry newborn screening in Australia. Pediatrics. 2009;123(2):451–7.

    Article  PubMed  Google Scholar 

  24. Li Y, Scott CR, Chamoles NA, et al. Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. Clin Chem. 2004;50(10):1785–96.

    Article  CAS  PubMed  Google Scholar 

  25. Metz TF, Mechtler TP, Orsini JJ, et al. Simplified newborn screening protocol for lysosomal storage disorders. Clin Chem. 2011;57(9):1286–94.

    Article  CAS  PubMed  Google Scholar 

  26. Strom CM, Janeszco R, Quan F, et al. Technical validation of a TM Biosciences Luminex-based multiplex assay for detecting the American College of Medical Genetics recommended cystic fibrosis mutation panel. J Mol Diagn. 2006;8(3):371–5.

    Article  CAS  PubMed  Google Scholar 

  27. Sista RS, Eckhardt AE, Wang T, et al. Digital microfluidic platform for multiplexing enzyme assays: implications for lysosomal storage disease screening in newborns. Clin Chem. 2011;57(10):1444–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory Medicine, Children’s National Medical Center, 111 Michigan Avenue, NW, Washington, DC, USA

    Sean Hofherr Ph.D.

  2. Laboratory Genetics, Mayo Clinic, 200 First Street SW, Rochester, MN, USA

    Devin Oglesbee Ph.D.

  3. Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA

    Devin Oglesbee Ph.D.

  4. Department of Medical Genetics, Mayo, Clinic, 200 First Street SW, Rochester, MN, USA

    Devin Oglesbee Ph.D.

Authors
  1. Sean Hofherr Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Devin Oglesbee Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sean Hofherr Ph.D. .

Editor information

Editors and Affiliations

  1. Medicine and Pathology Molecular Genetics Laboratory, Mayo Clinic College of Medicine Department of Laboratory, Rochester, Minnesota, USA

    W. Edward Highsmith, Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hofherr, S., Oglesbee, D. (2014). Newborn Screening by Tandem Mass Spectrometry and Molecular Confirmation. In: Highsmith, Jr., W. (eds) Molecular Diagnostics. Molecular and Translational Medicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-8127-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8127-0_12

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4614-8126-3

  • Online ISBN: 978-1-4614-8127-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation